PlainRecalls
FDA Drug Critical Class I Terminated

Heparin Sodium 2,500 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (5 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0655-44, Bar Code 70004065544.

Reported: September 2, 2020 Initiated: July 29, 2020 #D-1550-2020

Product Description

Heparin Sodium 2,500 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (5 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0655-44, Bar Code 70004065544.

Reason for Recall

Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

Details

Recalling Firm
SCA Pharmaceuticals
Units Affected
1,097 Containers
Distribution
Nationwide within the U.S.
Location
Windsor, CT

Frequently Asked Questions

What product was recalled?
Heparin Sodium 2,500 units in 0.9% Sodium Chloride 500 mL, Single Dose Container, Rx Only Injection for Intravenous Use (5 units/mL), SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC#: 70004-0655-44, Bar Code 70004065544.. Recalled by SCA Pharmaceuticals. Units affected: 1,097 Containers.
Why was this product recalled?
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 2, 2020. Severity: Critical. Recall number: D-1550-2020.